Four-Year Durability of Initial Combination Therapy with Sitagliptin and Metformin in Patients with Type 2 Diabetes in Clinical Practice; COSMIC Study-Reference-Cited by-同舟云学术

Four-Year Durability of Initial Combination Therapy with Sitagliptin and Metformin in Patients with Type 2 Diabetes in Clinical Practice; COSMIC Study

Published:2015-06-12 Issue:6 Volume:10 Page:e0129477
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Ku Eu Jeong,Jung Kyong Yeon,Kim Yoon Ji,Kim Kyoung Min,Moon Jae Hoon,Choi Sung Hee,Cho Young Min,Park Kyong Soo,Jang Hak Chul,Lim Soo,Ahrén Bo

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference38 articles.

1. Dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes: a comparative review;CF Deacon;Diabetes Obes Metab,2011

2. Efficacy and tolerability of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy over 12 weeks in patients with type 2 diabetes;R Scott;Int J Clin Pract,2007

3. Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus;JJ Neumiller;Pharmacotherapy,2010

4. Evaluating second-line treatment options for type 2 diabetes: focus on secondary effects of GLP-1 agonists and DPP-4 inhibitors;CL Boland;Ann Pharmacother,2013

5. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone;B Charbonnel;Diabetes Care,2006

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modern approaches to the treatment of diabetes mellitus: A review. Moscow City Congress of Endocrinologists “Endocrinology of the capital – 2024”. Review of the congress on March 29–31, 2024;Consilium Medicum;2024-05-20

2. Benefits and risks of drug combination therapy for diabetes mellitus and its complications: a comprehensive review;Frontiers in Endocrinology;2023-12-19

3. National Council of Experts: the place of DPP-4 inhibitors in the treatment of patients with type 2 diabetes mellitus;Diabetes mellitus;2023-12-06

4. A Review: Comparison of Efficacy of Liraglutide Versus Sitagliptin add-on-to Metformin in Type 2 Diabetes Mellitus patients;Research Journal of Pharmacy and Technology;2021-04-29

5. Type II diabetes mellitus: a review on recent drug based therapeutics;Biomedicine & Pharmacotherapy;2020-11